Thurmont plans to add filtration equipment to all three of its water treatment facilities to mitigate “forever chemicals” found in its wells, using forgivable loans from the state totaling more than ...
Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...
Groundbreaking research exposes how diabetes damages kidneys, offering hope through early detection and innovative prevention ...
Nearly all children with ANCA-associated vasculitis demonstrate active kidney disease at diagnosis, and their renal function ...
The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...
Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25. If approved, FILSPARI could be the first and only approv ...
Huong of the National Children's Hospital in Hanoi received a call late on December 18, 2024 from the National Center for ...
Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25 If approved, FILSPARI could be the first and only approved medicine indicated ...
As pet owners, we want the best for our companions. Between making sure they're fed, safe, and happy, it's easy to feel ...
Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.
Body weight cycling, also known as “yo-yo dieting,” is associated with a 25%-36% increased risk for diabetic kidney disease ...
GlobalData on MSN18h
Travere takes rare disease kidney drug to FDA despite failed trialTravere’s stock price climbed by 14% following the announcement it will seek an FDA label expansion for Filspari.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback